Company Information

Medicamen Organics Limited was incorporated in March 1995 and is engaged in the development, manufacture and distribution of a wide range of pharmaceutical preparations including generic preparations in the form of tablets, capsules, oral liquids, ointments, gels, syrups, suspensions and dry powders for the Government (including State Governments and Central Government) and private entities as contract manufacturers/third party manufacturers.

They market their products to private pharmaceutical companies in the domestic and international markets through third party distributors or on a loan license basis. In addition, the company is strategically focused on establishing a direct presence on the international market. In the 2023 financial year, for example, it exported its product directly to Burundi. The company has a proven track record of operating a B2B model, which includes a contract manufacturing model. The products are distributed across India as well as in African, CIS and South East Asian countries such as Congo, Benin, Kameg, Togo, Senegal, Burkina Faso, Philippines, Myanmar, Mozambique, Togo, Burundi, Kyrgyzstan and Kenya through a third-party distributor.

The company has two WHO approved manufacturing facilities at 60 and 61, Sector 6A, I.I.E. SIDCUL, Ranipur, Haridwar 249403, Uttarakhand, spread over an area of 21,536 square meters. The manufacturing facilities are capable of producing pharmaceutical formulations and products and have a fully equipped quality control department with experienced and qualified personnel to facilitate a smooth manufacturing process. The company has an in-house testing laboratory and the necessary infrastructure to test its raw materials and finished products for compliance with quality standards.

GEM Enviro SME IPO Strengths

• Experienced promoter and management team.
• Wide range of products.
• Scalable business model.
• Quality assurance.

GEM Enviro SME IPO Objective

The company proposes to utilize the Net Proceeds from the Issue towards the following objects:

1. Funding of expenses proposed to be incurred towards Product registration in the international markets;
2. Plant updation and increase in production capacity;
3. Funding working capital requirements of our Company; and
4. General Corporate Purposes.